Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library (2014)
- Autores:
- Autores USP: YASUNAKA, JENICER KAZUMI UMADA YOKOYAMA - ICB ; ULIANA, SILVIA RENI BORTOLIN - ICB
- Unidade: ICB
- DOI: 10.1111/cbdd.12239
- Assunto: PARASITOLOGIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Chemical Biology Drug Design
- ISSN: 1747-0285
- Volume/Número/Paginação/Ano: v. 83, n. 3, p. 289-296, 2014
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BONANO, Vivian I. et al. Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library. Chemical Biology Drug Design, v. 83, n. 3, p. 289-296, 2014Tradução . . Disponível em: https://doi.org/10.1111/cbdd.12239. Acesso em: 19 set. 2024. -
APA
Bonano, V. I., Yokoyama-Yasunaka, J. K. U., Miguel, D. C., Jones, S. A., Dodge, J. A., & Uliana, S. R. B. (2014). Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library. Chemical Biology Drug Design, 83( 3), 289-296. doi:10.1111/cbdd.12239 -
NLM
Bonano VI, Yokoyama-Yasunaka JKU, Miguel DC, Jones SA, Dodge JA, Uliana SRB. Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library [Internet]. Chemical Biology Drug Design. 2014 ; 83( 3): 289-296.[citado 2024 set. 19 ] Available from: https://doi.org/10.1111/cbdd.12239 -
Vancouver
Bonano VI, Yokoyama-Yasunaka JKU, Miguel DC, Jones SA, Dodge JA, Uliana SRB. Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library [Internet]. Chemical Biology Drug Design. 2014 ; 83( 3): 289-296.[citado 2024 set. 19 ] Available from: https://doi.org/10.1111/cbdd.12239 - Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool
- Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis
- Antileishmanial activity of the estrogen receptor modulator raloxifene
- The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice
- A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient
- Combination therapy with Tamoxifen and Amphotericin B in experimental cutaneous Leishmaniasis
- Leishmania amazonensis META2 protein confers protection against heat shock and oxidative stress
- Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial
- The extraordinary case of a woman with a 30-year-long diffuse Leishmaniasis cured with one single ampoule of intranasal pentavalent antimoniate
- In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B
Informações sobre o DOI: 10.1111/cbdd.12239 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
